Search -

Displaying 1 - 20 of 1414

Sort: Relevancy | Date

News Daily News

Chemo-Induced Vascular Dysfunction More Likely When Breast Cancer Occurs After Menopause

Yael L. Maxwell

January 23, 2026

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

L.A. McKeown

January 16, 2026

News Daily News

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

Michael O'Riordan

January 09, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

CAC Predicts Obstructive CAD, but Thresholds Diverge by Sex

L.A. McKeown

January 06, 2026

News Daily News

Year in Review: Reimbursement, Funding Cuts Mark Top Policy & Practice News

Yael L. Maxwell

December 26, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Features

Year in Review: Women’s Heart Health in the Spotlight

Caitlin E. Cox

December 23, 2025

News Daily News

ANOCA May Not Be as Risky as Feared: Danish Data

Caitlin E. Cox

December 15, 2025

News Daily News

Uterine Fibroids Increase Future Risk of ASCVD for Up to 10 Years

Caitlin E. Cox

December 10, 2025

News Daily News

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

Yael L. Maxwell

December 02, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Daily News

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

Caitlin E. Cox

November 21, 2025

News Conference News AHA 2025

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

Michael O'Riordan

November 14, 2025

News Daily News

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

Yael L. Maxwell

November 13, 2025

News Conference News AHA 2025

Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials

Yael L. Maxwell

November 13, 2025

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Conference News TCT 2025

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

Caitlin E. Cox

October 28, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

Advertisement

Chemo-Induced Vascular Dysfunction More Likely When Breast Cancer Occurs After Menopause

January 2026 Dispatch for the CV Team

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

CAC Predicts Obstructive CAD, but Thresholds Diverge by Sex

Year in Review: Reimbursement, Funding Cuts Mark Top Policy & Practice News

December 2025 Dispatch for the CV Team

Year in Review: Women’s Heart Health in the Spotlight

ANOCA May Not Be as Risky as Feared: Danish Data

Uterine Fibroids Increase Future Risk of ASCVD for Up to 10 Years

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

November 2025 Dispatch for the CV Team

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content